Blogs

Get to know ASCPT member @Caroline Grant ! Caroline Grant, PhD, Senior Clinical Pharmacologist, AbbVie, North Chicago, Illinois What is your favorite part of being an ASCPT 2026 Session Chair? Working with such an outstanding group of speakers – Drs. Nadia Terranova, Kristin Bigos, Matt Rizk, and Ben Weber – and my co-chair, Mohamed Shahin, was my favorite part. I gained a great deal not only from their insights on the role of AI/ML in drug development, but also from the creativity they brought to the debate session format. Debating in front of a crowd, especially with limited time, can be challenging, but they handled it with ease and made it ...
Get to know ASCPT member @Caroline Grant ! Caroline Grant, PhD, Senior Clinical Pharmacologist, AbbVie, North Chicago, Illinois What is your favorite part of being an ASCPT 2026 Session Chair? Working with such an outstanding group of speakers – @Nadia Terranova , @Kristin Bigos , @Matthew Rizk, and @Benjamin Weber – and my co-chair, @Mohamed Shahin, was my favorite part. I gained a great deal not only from their insights on the role of AI/ML in drug development, but also from the creativity they brought to the debate session format. Debating in front of a crowd, especially with limited time, can be challenging, but they handled it with ease ...
Get to know ASCPT member @Tesfaye Hailemariam ! Tesfaye Hailemariam, PhD, Early Career Researcher, Addis Ababa University and Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia What is your favorite part of being part of the LMIC Accelerator Cohort? My favorite aspect of the LMIC Accelerator Cohort is the opportunity to engage with a diverse and highly motivated group of scientists who are committed to advancing clinical pharmacology in resource-limited settings. The program fosters meaningful mentorship, collaboration, and knowledge exchange, while also empowering us to translate science into solutions that address real-world health ...
Get to know ASCPT members @Md Abu Siddique and @Sonya Tang Girdwood ! Md Abu Siddique, MS, University of Florida, Gainesville, Florida What does being a 2026 Presidential Trainee mean to you? Being selected as a 2026 Presidential Trainee Award Recipient is one of the most important milestones of my career so far. Growing up in Dhaka, Bangladesh, I never imagined that my journey would take me from working as a pharmacist in the pharmaceutical industry in Bangladesh and Kenya to pursuing cutting-edge research at the University of Florida. This award is a reminder that the unconventional path I took, leaving a stable career after six and a half ...
Get to know ASCPT member @Natalie Jusko ! Natalie Jusko, PhD, Clinical Pharmacology Lead, Pfizer, New York, NY Why did you submit your abstract for presentation at the ASCPT 2026 Annual Meeting? ASCPT is a space where methodological innovation is closely tied to clinical relevance and patient impact. I wanted to share my work in a setting where the focus is not just on developing models but on how those models can be used to inform meaningful decisions in drug development. It was also an excellent opportunity to receive feedback from experts who think deeply about the practical applications of these approaches. What does being a 2026 Presidential ...
Get to know ASCPT member @Xuanzhen Yuan ! Xuanzhen Yuan, MS, Graduate Research Assistant, University of Iowa, Iowa City, Iowa What does being a 2026 Presidential Trainee mean to you? Being selected as a 2026 Presidential Trainee Award Recipient is a very special honor to me, especially during the final year of my PhD. It feels like meaningful recognition of the many years of work, growth, and persistence behind this journey, as well as the support and mentorship that helped shape it. It also gives me confidence as I prepare for the next step in my career. When you are not working, how do you spend your free time? In my free time, I enjoy spending ...
Get to know ASCPT members @Enzama Henry and @Jean Malave ! Henry Enzama, MS, Maternal, Infant, and Lactation Pharmacokinetics Group, Infectious Diseases Institute (IDI), Makerere University, Kampala, Uganda Why did you become a member of ASCPT? I became a member of ASCPT to engage more deeply with the global clinical pharmacology and translational science community and to contribute to advancing model-informed drug development, particularly for underserved populations. How does being a member of ASCPT help you connect with the global clinical pharmacology community? ASCPT connects me with a diverse network of researchers and clinicians through ...
Get to know ASCPT member @Moataz Mohamed ! Moataz Mohamed, MSc, University of Minnesota, Minneapolis, MN What does being the 2026 David Goldstein Award and a 2026 Presidential Trainee Award Recipient mean to you? Receiving the 2026 David Goldstein Award and being a Presidential Trainee is a tremendous honor and means a great deal to me. The project for which I received this recognition represents years of preparation and effort, from designing the study and acquiring samples to conducting wet lab work, curating and analyzing the data, and ultimately completing the analysis. These awards are both humbling and motivating, and they inspire me to ...
Get to know ASCPT members @Lance Kuo-Esser and @Yifan Zheng ! Lance Kuo-Esser, BS, Graduate Student, Cincinnati Children's, Cincinnati, Ohio, USA What does being a 2026 Presidential Trainee Award Recipient mean to you? It tells me that work at the intersection of pharmacometrics, clinical pharmacology, and translational decision-making is valued. I see it less as a finish line and more as confirmation that we are asking the right questions, with a responsibility to focus on work that is not just technically sound, but clinically useful. Why did you submit your abstract for presentation at the ASCPT 2026 Annual Meeting? I submitted my abstract ...
Get to know ASCPT member @Praveen Devanandan ! Praveen Devanandan, PharmD, PhD, Head, Department of Pharmacy Practice, St. Peter's Institute of Pharmaceutical Sciences, Hanamkonda, India What is your favorite part of being part of the LMIC Accelerator Cohort? Being part of the LMIC Accelerator Cohort offers a unique platform to collaborate with professionals who understand the contextual challenges of low- and middle-income countries. I particularly value the exchange of ideas, meeting diverse experts, and learning directly from the initiatives and expertise within ASCPT. These interactions help translate global best practices into region-specific, ...
Get to know ASCPT member @Veronique Michaud ! Veronique Michaud, PhD, President, Galenus Rx, Orlando, Florida What does being the 2026 Malle Jurima-Romet Mid-Career Leadership Award Recipient mean to you? The Malle Jurima-Romet Mid-Career Leadership Award is deeply meaningful to me; it reflects a journey shaped by mentorship, teamwork, and trust. I began my training with very limited research experience and was fortunate to be welcomed into environments that emphasized scientific rigor, ethical responsibility, and patient-centered research. This award reminds me that leadership is not an individual achievement; it is the result of collective effort, ...
Get to know ASCPT member @Ganesh Prasad Neupane ! Ganesh Prasad P. Neupane, MD, DDS, Associate Professor, Medical University Of The Americas, Nevis, Charlestown, Newcastle, Nevis, Saint Kitts and Nevis What is your favorite part of being part of the LMIC Accelerator Cohort? My favorite part of being part of the LMIC Accelerator Cohort has been the opportunity to collaborate with a diverse group of professionals who share a common commitment to advancing clinical pharmacology in resource-limited settings. The cohort has provided a platform to learn innovative approaches to research, education, and capacity building that are directly applicable to ...
Did you know ASCPT has three Identity Groups members can affiliate with? ASCPT Identity Groups foster a feeling of belonging among the diverse members of the Society. These groups create meaningful engagement opportunities and encourage sharing and mentorship. This week, we're highlighting the LGBTQIA+ Identity Group, coordinated by @Shayna Killam ! The mission for the ASCPT LGBTQIA+ Identity Group is to foster a welcoming, inclusive, and supportive environment for LGBTQIA+ individuals and their allies in the professional world of Clinical Pharmacology and Therapeutics. They are committed to: Advocacy and Awareness: Promoting understanding and ...
Get to know ASCPT member @Emily Cicali ! Emily Cicali, PharmD, Clinical Associate Professor, University of Florida, Ocala, Florida, USA What professional accomplishment are you most proud of? Having established University of Florida Health's virtual outpatient PGx consult clinic, MyRx. The clinic is run by the College of Pharmacy, and we are able to help patients and their doctors understand their PGx results. In addition to helping patients, it provides a plethora of learning opportunities for students and postdoctoral trainees. Do you have a favorite tip or trick for clinical practice or research that you want to share with fellow members? ...
Get to know ASCPT members @Paola Mian ! Paola Mian, PharmD, PhD, Clinical Pharmacist, Clinical Pharmacologist, Toxicologist (ERT), Groningen, Netherlands What is your favorite society memory? My favorite Society memory is from 2019, when I joined ASCPT for the first time as a fourth-year PhD student. During that meeting, I met several inspiring people – one of them being Dr. Paul Malik, who at the time was also still a PhD student. Over the years, we stayed in touch and collaborated on various PBPK projects aimed at developing better drugs for children and pregnant women. In fact, one of those projects resulted in the invitation of working on ...
Get to know ASCPT member @Vikram Arya ! Vikram Arya, PhD, Head of Clinical Pharmacology (West Coast Hub), Biogen, Inc., Weston, Florida, USA What does being the Membrane Transporter (MT) Community Vice Chair mean to you? Serving as Co-Vice Chair of the Membrane Transporter Community entails a commitment to stewardship of the discipline, with a focus on fostering scientific growth and innovation to advance the field of drug transporters. I aspire to engage in meaningful collaborations with a diverse group of professionals to design and implement educational initiatives, foster interdisciplinary engagement, and expand and strengthen my professional ...
Get to know ASCPT member @Sabina Paglialunga ! Sabina Paglialunga, PhD, Senior Director, Scientific Affairs, Celerion, Tempe, Arizona, USA Why do you choose to stay a member of ASCPT? There are several benefits associated with ASCPT membership that have contributed to my decision to remain with the organization. As a member, I have access to high-caliber clinical pharmacology meetings and webinars, as well as articles through CPT and CTS . In addition, ASCPT offers opportunities to present my research via review articles and poster presentations. I also appreciate the many networking opportunities, such as connecting with colleagues and ...
Get to know ASCPT member @Ewoud-Jan van Hoogdalem ! Ewoud-Jan van Hoogdalem, PharmD, PhD, Leiden, OC, Netherlands Why did you decide to join ASCPT? Like any science, the science of clinical pharmacology is a global one. ASCPT offers me, in Europe, the opportunity to connect with and learn from well-respected colleagues on the American continent, and from all others also attending ASCPT events and involved in ASCPT. How has your membership in ASCPT benefited your career? Being involved in ASCPT simply made my world bigger. Every involvement in an ASCPT event was and is an opportunity for me to learn, to do my job better, and to enjoy connecting ...
Get to know ASCPT member @Shruti Shah ! Shruti Shah, PhD, Associate Director, Quantitative Clinical Pharmacology, GlaxoSmithKline, Brookline, Massachusetts What does being the Translational Informatics (TI) Community Vice Chair mean to you? It means an opportunity to serve the ASCPT community by sharing learnings about novel tools and applications of Translational Informatics for Clinical Pharmacology questions. What is your favorite part of being a Translational Informatics (TI) Community Vice Chair? I enjoy meeting and learning from folks with different perspectives and scientific expertise. I also enjoy collaborating on achieving the group's ...
Get to know ASCPT member @Mark Lovern ! Mark Lovern, PhD, Executive Director, Medical Science Services, Fortrea, Raleigh, North Carolina Why did you decide to join ASCPT? I joined ASCPT to broaden my perspective beyond my core area of expertise (pharmacometrics) and engage with a wider variety of colleagues and constituencies contributing to pharmaceutical R&D. As a member for 16 years, why have you decided to stay with ASCPT? ASCPT has done an amazing job of evolving to meet the needs of our ever-changing industry. Staying involved with ASCPT has helped me stay current with the latest trends and topics in clinical and quantitative pharmacology. ...